Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Caroline Arber

Showing results (31-40 of 47) with videos related to

Pageof 5
Sort By:
Annals of Hematology|January 14, 2009
Aplastic anemia and concomitant autoimmune diseasesMagnus P Stalder, Alicia Rovó, Jörg Halter, et al.
Cytotherapy|December 6, 2011
Initial cord blood unit volume affects mononuclear cell and CD34+ cell-processing efficiency in a non-linear fashionSandrine Meyer-Monard, André Tichelli, Carolyn Troeger, et al.
Scientific Reports|June 4, 2016
T cells expressing CD19-specific Engager Molecules for the Immunotherapy of CD19-positive MalignanciesMireya Paulina Velasquez, David Torres, Kota Iwahori, et al.
Blood|October 29, 2017
c-MPL provides tumor-targeted T-cell receptor-transgenic T cells with costimulation and cytokine signalsChristopher D Nishimura, Daniel A Brenner, Malini Mukherjee, et al.
Nature Biomedical Engineering|November 25, 2025
Author Correction: Computational design of synthetic receptors with programmable signalling activity for enhanced cancer T cell therapyJan A Rath, Lucas S P Rudden, Nazila Nouraee, et al.
Nature Biomedical Engineering|October 29, 2025
Computational design of synthetic receptors with programmable signalling activity for enhanced cancer T cell therapyJan A Rath, Lucas S P Rudden, Nazila Nouraee, et al.
European Journal of Haematology|March 17, 2009
Infection prevention strategies in a stem cell transplant unit: impact of change of care in isolation practice and routine use of high dose intravenous immunoglobulins on infectious complications and transplant related mortalityNathan Cantoni, Maja Weisser, Andreas Buser, et al.
Frontiers in Immunology|April 17, 2026
Case Report: Transverse myelitis following CAR-T cell therapy for post-transplant lymphoproliferative disorderNicolas Desbaillets, Ana Isabel Martín-Quesada, Arthur Mulvey, et al.
Cancer Immunology Research|February 17, 2022
A Costimulatory CAR Improves TCR-based Cancer ImmunotherapyBilal Omer, Mara G Cardenas, Thomas Pfeiffer, et al.
Swiss Medical Weekly|October 28, 2024
Technical comment on: Trottmann M, et al. Real-world expenditures and survival time after CAR-T treatment for large B-cell lymphoma in Switzerland: a retrospective study using insurance claims dataCaroline Arber, Gabriela Baerlocher, Yves Chalandon, et al.
Pageof 5

Showing results (31-40 of 47) with videos related to

Sort By:
Pageof 5
Annals of Hematology|January 14, 2009
Aplastic anemia and concomitant autoimmune diseasesMagnus P Stalder, Alicia Rovó, Jörg Halter, et al.
Cytotherapy|December 6, 2011
Initial cord blood unit volume affects mononuclear cell and CD34+ cell-processing efficiency in a non-linear fashionSandrine Meyer-Monard, André Tichelli, Carolyn Troeger, et al.
Scientific Reports|June 4, 2016
T cells expressing CD19-specific Engager Molecules for the Immunotherapy of CD19-positive MalignanciesMireya Paulina Velasquez, David Torres, Kota Iwahori, et al.
Blood|October 29, 2017
c-MPL provides tumor-targeted T-cell receptor-transgenic T cells with costimulation and cytokine signalsChristopher D Nishimura, Daniel A Brenner, Malini Mukherjee, et al.
Nature Biomedical Engineering|November 25, 2025
Author Correction: Computational design of synthetic receptors with programmable signalling activity for enhanced cancer T cell therapyJan A Rath, Lucas S P Rudden, Nazila Nouraee, et al.
Nature Biomedical Engineering|October 29, 2025
Computational design of synthetic receptors with programmable signalling activity for enhanced cancer T cell therapyJan A Rath, Lucas S P Rudden, Nazila Nouraee, et al.
European Journal of Haematology|March 17, 2009
Infection prevention strategies in a stem cell transplant unit: impact of change of care in isolation practice and routine use of high dose intravenous immunoglobulins on infectious complications and transplant related mortalityNathan Cantoni, Maja Weisser, Andreas Buser, et al.
Frontiers in Immunology|April 17, 2026
Case Report: Transverse myelitis following CAR-T cell therapy for post-transplant lymphoproliferative disorderNicolas Desbaillets, Ana Isabel Martín-Quesada, Arthur Mulvey, et al.
Cancer Immunology Research|February 17, 2022
A Costimulatory CAR Improves TCR-based Cancer ImmunotherapyBilal Omer, Mara G Cardenas, Thomas Pfeiffer, et al.
Swiss Medical Weekly|October 28, 2024
Technical comment on: Trottmann M, et al. Real-world expenditures and survival time after CAR-T treatment for large B-cell lymphoma in Switzerland: a retrospective study using insurance claims dataCaroline Arber, Gabriela Baerlocher, Yves Chalandon, et al.
Pageof 5